Bio

As Founder, Chief Executive Officer and Board Chair, Ms. Wahaus has led the strategic planning, business development, manufacturing, regulatory, clinical trial and commercialization activities of ELIAS since 2014. Ms. Wahaus has 25+ years of experience serving in key leadership roles in public and private companies. She joined TVAX Biomedical (an affiliate) in 2012 as Chief Financial Officer and developed the animal health spin-off strategy. Previously, Ms. Wahaus was an audit partner and national office advisor with Ernst & Young LLP. She also served as Global Controller and Principal Accounting Officer for a GE Global Insurance Holdings, where she oversaw the global accounting and reporting operations across four continents and implemented Six Sigma Quality process management systems in finance. She is a graduate of Kansas State University (BS Business Administration, Accounting) and serves as an advisory board member for the KSU College of Business.